DIETARY INTERVENTIONS INFLUENCING NEUROLOGICAL OUTCOMES
Carolina Blagojevic Castro
Dietician/Nutritionist,
PhD Candidate at Murdoch University, Western Australia &
Research Assistant, Alzheimer’s Research Australia
RESEARCHER PROFILE
Filmed in Perth, Western Australia | September 2024
With over a decade of experience as a dietitian and nutritionist, Carolina Blagojevic Castro specialises in providing personalised dietary guidance and customised meal planning tailored to meet each client’s unique health needs. She is known for her engaging and educational presentations on topics related to health and nutrition, sharing practical, evidence-based insights with both community groups and professional audiences.
Currently, she works as a Nutritionist and Research Assistant at Alzheimer’s Research Australia, supporting studies on the links between diet and cognitive health. This role deepens her expertise in neurology-related nutrition, allowing her to explore how dietary interventions may influence neurological outcomes. She is also a PhD candidate at the Centre for Healthy Ageing at Murdoch University in Perth, Australia, where she merges her hands-on experience with academic research, contributing practical insights to the field of nutritional science. Her research focuses on the interplay between diet and aging, bridging real-world applications and theoretical knowledge to advance the understanding of nutrition’s impact on healthy aging.
In addition to her role at Murdoch University, she holds a postgraduate qualification in Neurological Diseases from Philadelphia University/UniFil in Brazil, further enhancing her capacity to address complex dietary needs. Her commitment to professional development ensures that she stays at the forefront of advancements in nutrition, providing care to her clients and contributing meaningfully to her field.
You Might also like
-
Anne O’Neill
STATE GOVERNMENT SUPPORTING MEDICAL RESEARCH
@ NSW HEALTH, NEW SOUTH WALES AUSTRALIA -
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Dr Meghan McIlwain
DR MEGHAN MCILWAIN, CLINICAL RESEARCH MANAGER
PRESIDENT, THE NEW ZEALAND ASSOCIATION OF CLINICAL RESEARCH,
AUCKLAND, NEW ZEALAND